Stockscreener 앱 받기
29.78
0.07%
-0.12
Vaxcyte Inc 주식(PCVX)의 최신 뉴스
Guggenheim lowers Vaxcyte stock price target to $116 on trial timeline shifts - Investing.com Canada
Vaxcyte’s Strategic Advancements and Financial Stability Justify Buy Rating - TipRanks
Vaxcyte, Inc. shares fall 9.56% intraday after FDA interactions and Phase 3 clinical program finalization. - AInvest
Vaxcyte price target lowered to $50 from $85 at TD Cowen - TipRanks
Vaxcyte’s Strategic Adjustments and Optimized Trials Drive Buy Rating - TipRanks
Vaxcyte Q2 EPS $1.22, beats consensus $1.16; CEO discusses Phase 3 program for VAX-31. - AInvest
Vaxcyte (PCVX) Q2 Loss Widens 11% - AOL.com
Vaxcyte (PCVX) Q2 Loss Widens 11% - The Motley Fool
Promising Prospects for Vaxcyte’s VAX-31: Strong Adult Trial Results and Strategic Advancements in Infant Studies Reinforce Buy Rating - TipRanks
Vaxcyte Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Vaxcyte Reports Second Quarter 2025 Financial Results and Provides Business Update, Highlighting Key Clinical and Regulatory Progress for VAX-31, a Potential Best-in-Class Pneumococcal Conjugate Vaccine (PCV) - GlobeNewswire
Vaxcyte's VAX-31 Vaccine Gets FDA Green Light for Phase 3 Launch: $2.8B War Chest Powers Clinical Progress - Stock Titan
MACD Signals Flash Warning for Vaxcyte Inc. StockMulti-Bagger Potential Stock Forecast Tools Released - metal.it
What is the dividend policy of Vaxcyte Inc. stockStay ahead with advanced stock screening tools - Jammu Links News
How strong is Vaxcyte Inc. company’s balance sheetUnprecedented profits - Jammu Links News
How does Vaxcyte Inc. compare to its industry peersDiscover stocks with explosive upside potential - Jammu Links News
Is Vaxcyte Inc. stock overvalued or undervaluedAchieve breakthrough performance in the market - Jammu Links News
Is Vaxcyte Inc. a growth stock or a value stockFree Investment Risk Control - Jammu Links News
How does Vaxcyte Inc. generate profit in a changing economyAchieve rapid financial growth with smart picks - Jammu Links News
When is Vaxcyte Inc. stock expected to show significant growthUnlock powerful stock screening tools today - Jammu Links News
Is it the right time to buy Vaxcyte Inc. stockDiscover stocks with explosive growth potential - Jammu Links News
What drives Vaxcyte Inc. stock priceInvest smarter with real-time trading signals - Jammu Links News
What are the latest earnings results for Vaxcyte Inc.Stay ahead with advanced stock screening tools - Jammu Links News
What are analysts’ price targets for Vaxcyte Inc. in the next 12 monthsBuild a diversified portfolio for steady growth - Jammu Links News
Should I hold or sell Vaxcyte Inc. stock in 2025Phenomenal capital appreciation - Jammu Links News
What institutional investors are buying Vaxcyte Inc. stockPowerful profit generation - Jammu Links News
InvestingPro’s Fair Value model predicted Vaxcyte’s 46% decline By Investing.com - Investing.com
Vaxcyte, Inc. (PCVX)’s VAX-24 Achieves Phase 2 Success in Infants - Yahoo Finance
What markets is Vaxcyte Inc. expanding into Is FDUS stock a good long term investment optionFree Stock Target Finder That Work - Jammu Links News
11 Best Future Stocks to Buy Now - Insider Monkey
What makes Vaxcyte Inc. stock price move sharplyMarket Entry and Exit Point Tips From Traders - metal.it
What is the risk reward ratio of investing in Vaxcyte Inc. stockInvest smarter with daily stock recommendations - Jammu Links News
What catalysts could drive Vaxcyte Inc. stock higher in 2025Rapid growth trajectories - Jammu Links News
1.52%
0.80%
자본화:
|
볼륨(24시간):